Fundraising Fox
Organo-ID
Founded 2020 · 7 employees on LinkedIn · 1 known investors
Find your way into Organo-ID
Sign up to find every way you can get introduced to Organo-ID
- Your email: who you already know at Organo-ID, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Organo-ID team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.
Founders & leadership
Organo-ID was founded in 2020 by Prof. Dr. Erdal, Bugraer Aslan, and Esra Erdal.
Investors · 1
Frequently asked questions
- What does Organo-ID do?
- Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.
- Who founded Organo-ID?
- Organo-ID was founded by Prof. Dr. Erdal, Bugraer Aslan, Esra Erdal in 2020.
- Who are Organo-ID's investors?
- Organo-ID's investors include Idacapital.